Brevital Sodium

Par Health USA, LLC🇺🇸 United States

FDA Page

Effective Date: May 5, 2026
Approval ID: eccd8340-ead3-4363-8902-0c19d33aa2ac
Products: 1 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

BREVITAL (methohexital sodium) for injection, USP

Quick Stats

Total Products1

Labelers3

Label Sections31

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.